Claudin 18 (43–14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapyRiley J. Arseneau, Thomas Arnason, Emma Kempster et al.|Translational Oncology|2025Cited by 11
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019Joanna Gotfrit, Michael M. Vickers, Mohammed Harb et al.|Current Oncology|2021Cited by 6
Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinomaRiley J. Arseneau, Jeanette E. Boudreau, Jorge P. Mejia et al.|Frontiers in Immunology|2025Cited by 3
Glypican-3 and Cytokeratin-19 Expression in Pancreatic Cancer in a Canadian PopulationCarley Bekkers, Thomas Arnason, Ravi Ramjeesingh|Journal of Clinical Medicine|2024Cited by 1
Barriers to accessing healthcare services: A multidisciplinary approach towards improving pancreatic cancer survival in a Canadian province.Elizabeth Faour, Ravi Ramjeesingh, Bruce Colwell et al.|Journal of Clinical Oncology|2019Cited by 0